Drs. @Yujun__Wong & Adrielly Martins & @BenediktHofer present @AASLDtweets #TLM26
🤝 joint #GlobalPBC - @BavenoCoop study on
♻️ #Recompensation in
🟢 Primary Biliary Cholangitis #PBC

✅ Recompensation upon #UDCA treatment: 13-27%
🔮 MELD 3.0 predicts recompensation

Is carvedilol really the best nonselective beta-blocker in cirrhosis? A large observational study compared outcomes among cirrhosis patients who were prescribed carvedilol, propranolol, or nadolol. @rbganatra shares the key results: jwat.ch/47I0vHu

Intestinal barrier dysfunction assessed by confocal laser endomicroscopy correlates with cirrhosis severity and clinical outcome☆

JHEP Reports
jhep-reports.eu/article/S2589-…

#LiverX
🔑 take aways from @BavenoCoop VIII
nature.com/articles/s4157…

AI-guided biliary cannulation during ERCP: new technology unveiled at #UEGWeek 😍🤩

#Baveno VIII consensus in portal hypertension #CSPH
Full Consensus Report now @JHepatology @EASLnews

journal-of-hepatology.eu/article/S0168-…

#DeltaCure #ViralHepatitis #HDV
#Milano @EASLnews @BavenoCoop

#LiverX #LiverTiwtter
#Cirrhosis Risk Identifier model #CIRI

❓Beyond portal pressure:
❓what does CIRI really predict

@JHepatology
sciencedirect.com/science/articl…

#BavenoVIII – @BavenoCoop
out in @JHepatology
Advancing consensus in portal hypertension

journal-of-hepatology.eu/article/S0168-…

Usually i give lectuures on #LiverDisease #LiverX

Today i talked about #Investigator #Oversight
at the #DACH 🇩🇪 🇦🇹🇨🇭Symposium on #ClinicalTrials in #Innsbruck - GCP #DataManagement & more

@CrgMotion @MedUni_Wien @ViennaLiverNews

You can still apply to the EASL School on #PortalHypertension hosted in #Vienna
in September 23-24 in 2027

@BavenoCoop @EASLnews @AASLDtweets
--> easl.eu/event/portal-h…

#LiverX Liver Meeting in Barcelona
#IMTLD2026 @rabataller @VirginiaHdezGea @jcgarciapagan @docberza @anna_baiges

including a Symposium on #PortalHypertension honoring Jaume Bosch @BavenoCoop

Impressive recruitment numbers. Interesting results on the interaction of cardiovascularmetabolic risk factors and alcohol for 🟡 #liver #steatosis and 🕸️ #liver #fibrosis

📕 @LancetGastroHep
🔗sciencedirect.com/science/articl…

@EASLnews @APASLnews @AleksanderKrag

Congratulations to Benedikt Simbrunner (MD PhD)
for his Venia Docendi (#Habilitation)
building on his research on the Gut-Liver-Axis #GLA in #Cirrhosis.

@MedUni_Wien @CrgMotion @ViennaLiverNews

Dr. @georgkramer
of @MedUni_Wien in collaboration with @AstraZeneca

A machine learning approach to non-invasive prediction of hepatic decompensation in patients with #cirrhosis #ACLD

@JHepatology
sciencedirect.com/science/articl…

Baveno VIII Consensus Conference provides updated guidance on advanced chronic liver disease, portal hypertension and vascular liver disease

easl.eu/news/baveno-vi…

Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma - Younossi - 2026 - Liver International - Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/li…

Hey #LiverX #Liver Fellows
interested in #PortalHypertension
in #Cirrhosis & #PSVD

🇦🇹Vienna @EASLnews School
📩easl.eu/event/portal-h…
happening Sep 2027 @MedUni_Wien

@balcar_lorenz @MattiasMandorf1 @docberza @VirginiaHdezGea @mathiasjachs

🚨Applications for the #EASLSchools of Hepatology are open! 🚨

Explore the upcoming schools below and tell us: which one is on your list? 👇

🇭🇷Infections in advanced chronic liver diseases, 4-5 June 2027, Zagreb (Croatia)
easl.eu/event/infectio…

🇪🇸Challenges in the treatment noma, 25-26 June 2027, Madrid (Spain)
easl.eu/event/challeng…

🇳🇱EASL Bootcamp: bridging the gap between science & medicine in hepatology, 16-18 September 2027 Rotterdam (the Netherlands)
easl.eu/event/easl-boo…

🇦🇹Portal Hypertension, 23-24 September 2027, Vienna (Austria)
easl.eu/event/portal-h…

@IvaKosuta @manna_555 @idibaps @ChokshiLab @docberza @MattiasMandorf1 @ReibergerThomas

#LiverX

In a retrospective study, post-LT VITRO dynamics independently predicted mortality and portal hypertension-related events. Failure to normalize may identify patients at risk.

@ReibergerThomas @PDinjar1 @balcar_lorenz @BenediktHofer @MattiasMandorf1

doi.org/10.1097/LVT.00…